Iridex (IRIX) Cash & Equivalents (2010 - 2026)

Iridex's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $4.6 million for Q2 2026.

• In Q2 2026, Cash & Equivalents fell 36.57% year-over-year to $4.6 million; the TTM figure through Apr 2026 stood at $4.6 million (down 36.57% YoY), while the FY2026 annual figure was $6.0 million, up 152.53% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $4.6 million, down from $6.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $23.9 million in Q1 2022, with the low at $2.4 million in Q4 2024.
• The 5-year median for Cash & Equivalents is $7.1 million (2023), against an average of $9.7 million.
• The sharpest annual moves came in 2024 and 2026: Cash & Equivalents sank 66.06% in 2024, then jumped 152.53% in 2026.
• Iridex's Cash & Equivalents stood at $13.9 million in 2022, then tumbled by 49.48% to $7.0 million in 2023, then tumbled by 66.06% to $2.4 million in 2024, then jumped by 133.47% to $5.6 million in 2025, then dropped by 17.55% to $4.6 million in 2026.
• Business Quant data shows IRIX's Cash & Equivalents at $4.6 million in Q2 2026, $6.0 million in Q1 2026, and $5.6 million in Q3 2025.